Neuroendocrine effects of perfluorooctane sulfonate in rats.
Open Access
- 1 September 2003
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 111 (12), 1485-1489
- https://doi.org/10.1289/ehp.6128
Abstract
Perfluorooctane sulfonate (PFOS) is a degradation product of sulfonyl-based fluorochemicals that are used extensively in industrial and household applications. Humans and wildlife are exposed to this class of compounds from several sources. Toxicity tests in rodents have raised concerns about potential developmental, reproductive, and systemic effects of PFOS. However, the effect of PFOS on the neuroendocrine system has not been investigated thus far. In this study, adult female rats were injected intraperitoneally with 0, 1, or 10 mg PFOS/kg body weight (BW) for 2 weeks. Food and water intake, BW, and estrous cycles were monitored daily. At the end of treatment, PFOS levels in tissues were measured by high-performance liquid chromatography (HPLC) interfaced with electrospray mass spectrometry. Changes in brain monoamines were measured by HPLC with electrochemical detection, and serum corticosterone and leptin were monitored using radioimmunoassay. Treatment with PFOS produced a dose-dependent accumulation of this chemical in various body tissues, including the brain. PFOS exposure decreased food intake and BW in a dose-dependent manner. Treatment with PFOS affected estrous cyclicity and increased serum corticosterone levels while decreasing serum leptin concentrations. PFOS treatment also increased norepinephrine concentrations in the paraventricular nucleus of the hypothalamus. These results indicate that exposure to PFOS can affect the neuroendocrine system in rats.Keywords
This publication has 21 references indexed in Scilit:
- Interactions of flurochemicals with rat liver fatty acid-binding proteinToxicology, 2002
- Perfluorooctane Sulfonate in Oysters, Crassostrea virginica, from the Gulf of Mexico and the Chesapeake Bay, USAArchives of Environmental Contamination and Toxicology, 2002
- Rat and Rabbit Oral Developmental Toxicology Studies With Two Perfluorinated CompoundsInternational Journal of Toxicology, 2001
- PLASMA CHOLECYSTOKININ AND HEPATIC ENZYMES, CHOLESTEROL AND LIPOPROTEINS IN AMMONIUM PERFLUOROOCTANOATE PRODUCTION WORKERSDrug and Chemical Toxicology, 2000
- Specificity of interleukin–1β-induced changes in monoamine concentrations in hypothalamic nuclei: blockade by interleukin-1 receptor antagonistBrain Research Bulletin, 1998
- Correlations of catecholamine release in the medial preoptic area with proestrous surges of luteinizing hormone and prolactin: effects of aging.Endocrinology, 1994
- The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Dose-related effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal β-oxidationArchives of Toxicology, 1992
- Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferationExperimental and Molecular Pathology, 1987
- Isolated removal of hypothalamic or other brain nuclei of the ratBrain Research, 1973